Helen Horaitis
About Helen Horaitis
Helen Horaitis is a Senior Manager in Marketing for Immuno-Oncology at Bristol Myers Squibb in Melbourne, Australia, with extensive experience in oncology marketing and a strong background in digital marketing and project management.
Position at Bristol Myers Squibb
Helen Horaitis currently holds the position of Senior Manager, Marketing - Immuno-Oncology (Pan-Tumour) at Bristol Myers Squibb. Based in Melbourne, Victoria, Australia, she focuses on comprehensive marketing strategies to support the oncology business unit. Her role involves leading pivotal projects, such as the development of customer segmentation and persona profiles for the Immuno-Oncology division.
Previous Experience at Bristol Myers Squibb
Prior to her current role, Helen Horaitis served as the Marketing Lead for Haematology & Immuno-Oncology at Bristol Myers Squibb from 2015 to 2020. During her 5-year tenure, she played a critical role in enhancing the company’s reach in the oncology sector through various marketing initiatives and campaigns.
Career at Roche
Helen Horaitis spent a significant portion of her career at Roche, where she held multiple key positions. From 2000 to 2008, she worked as a Product Specialist Representative, followed by roles as Marketing Project Manager (2008-2009) and Brand Manager for Oncology (2009-2012). She finalized her tenure at Roche as Brand Manager for Oncology – Avastin mCRC, from 2012 to 2015. These roles enabled her to develop a deep understanding of the oncology market and further hone her marketing expertise.
Early Career and Education
Helen started her career in marketing at Cressey Chemicals, where she worked as a Marketing Officer from 1996 to 2000. She holds a Bachelor of Applied Science (BASc) in Chemistry from RMIT University. Additionally, she earned a Certificate in Digital Marketing from ADMA in 2009 and a Cert IV in Project Management from the Australian Institute of Management in 2008.
Key Projects and Initiatives
Helen Horaitis has led several impactful projects at Bristol Myers Squibb. She developed and launched a Pan-Tumour confidence strategy, resulting in increased market share across multiple indications. She also spearheaded the implementation of a new brand campaign across the portfolio, which enhanced brand recognition and engagement. Currently, she is working on a project to reinvent patient education to address health literacy issues using design thinking methodologies.